Long-term WT1 peptide vaccination for patients with acute myeloid leukemia with minimal residual disease

Leukemia. 2012 Jun;26(6):1410-3. doi: 10.1038/leu.2011.343. Epub 2011 Dec 13.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Cancer Vaccines / administration & dosage*
  • Humans
  • Immunotherapy*
  • Leukemia, Myeloid, Acute / immunology
  • Leukemia, Myeloid, Acute / therapy*
  • Male
  • Middle Aged
  • Neoplasm, Residual / immunology
  • Neoplasm, Residual / therapy*
  • Oligopeptides / administration & dosage
  • Oligopeptides / immunology*
  • Remission Induction
  • Time Factors
  • Vaccination

Substances

  • Cancer Vaccines
  • Oligopeptides